Skip to content

Multicenter Prospective Clinical Trial of Oligosaccharide Test Kit

Multicenter Prospective Clinical Trial of Oligosaccharide Test Kit

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR1900028697
Enrollment
Unknown
Registered
2019-12-31
Start date
2020-01-15
Completion date
Unknown
Last updated
2020-01-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hepatitis B related liver cancer

Interventions

Index test:Oligosaccharide&#32
Test&#32

Sponsors

Zhejiang University
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. Healthy group: Healthy people who are without HBV infection, cirrhosis, liver cancer and other related diseases; 2. Patients with chronic HBV infection:HBV infection lasts for more than half a year, including chronic hepatitis B patients, virus carriers and HBsAg carriers.Patients with chronic hepatitis B who received nucleoside analogues, interferon treatment are also included; 3. Liver cirrhosis group:Liver cirrhosis was confirmed by imaging and histology in patients with HBV related chronic hepatitis B; 4. Primary HCC group: (1) HBV is positive or the patient has a history of HBV; (2) HCC is diagnosed by pathological diagnosis; (3) HCC can be diagnosed by other clinical diagnosis methods. 5. Interfere group:Other primary and secondary liver cancer not related to hepatitis B virus; Patients with hepatitis C, alcoholic fatty liver, nonalcoholic fatty liver, drug-induced liver disease and autoimmune liver disease; Tumors except liver cancer.

Exclusion criteria

Exclusion criteria: 1. hemolysis specimens; 2. Specimens with unclear information; 3. HIV/AIDS patients,immunosuppressive treatment.

Design outcomes

Primary

MeasureTime frame
Sensitivity;Specificity;Total coincidence rate;

Countries

China

Contacts

Public ContactKaijin XU

the First Affiliated Hospital, College of Medicine, Zhejiang University

zdyxyxukaijin@163.com+86 13750870030

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026